News-Medical.Net on MSN2 天
Triple therapy reduces tumor burden and improves survival in glioblastoma models
A new research paper was published in Oncotarget , Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ ...
Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug
Sunshine Biopharma's K1.1 mRNA-LNP shows promise for HCC treatment in mice, while its 2024 revenue surged 45% to $34.9 ...
BioWorld4 天
Sunshine Biopharma’s K1.1-mRNA-LNP shows promise in HCC mouse model
Sunshine Biopharma Inc. has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA lipid nanoparticle (K1.1-mRNA-LNP) product as a novel therapeutic agent for ...
Sunshine Biopharma announces results from studies on K1.1-mRNA-LNP product
Sunshine Biopharma (SBFM) has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA Lipid ...
Silexion Therapeutics Unveils Innovative Expanded Development Plan for SIL204 Based on ...
The decision to expand the development plan follows recently reported promising preclinical findings demonstrating that ...